2026 ICD-10-CM Diagnosis Code Q85.9Phakomatosis, unspecified
ICD-10-CM Codes›Q00-Q99›Q80-Q89›Q85
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q85.9 is a billable ICD-10-CM diagnosis code for phakomatosis, unspecified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 826 through 830, 843 through 845. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified congenital anomalies.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q85.9 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Bilateral congenital hamartoma of irises
- Congenital hamartoma
- Congenital hamartoma of iris
- Congenital hamartoma of iris of left eye
- Congenital hamartoma of iris of right eye
- Congenital hamartoma of skin
- Connective tissue nevus of skin
- Hamartoma
- Hamartoma of duodenal gland
- Hamartoma of intestine
- Hamartoma of small intestine
- Hamartoma of tongue
- Heart defect, tongue hamartoma, polysyndactyly syndrome
- Linear basal cell nevus
- Neoplasm and/or hamartoma
- Neurocutaneous syndrome
- Paving stone nevus
- Port-wine stain in proteus syndrome
- Port-wine stain of skin
- Proteus syndrome
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Hamartosis NOS
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Hamartoma, hamartoblastoma - Q85.9
- Hamartosis - Q85.9
- Phakomatosis - See Also: specific eponymous syndromes; - Q85.9
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Hamartoma, hamartoblastoma
- Hamartosis
- Phakomatosis
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Proteus Syndrome
hamartoneoplastic malformation syndrome of uncertain etiology characterized by partial gigantism of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas (hemangioma), lipomas (lipoma), lymphangiomas (lymphangioma), epidermal nevi; macrocephaly; cranial hyperostosis, and long-bone overgrowth. joseph merrick, the so-called elephant man, apparently suffered from proteus syndrome and not neurofibromatosis, a disorder with similar characteristics.Hamartoma
a focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.Hamartoma Syndrome, Multiple
a hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. individuals with this syndrome have a high risk of breast cancer; thyroid cancer; and endometrial cancer. this syndrome is associated with mutations in the gene for pten phosphatase.Peutz-Jeghers Syndrome
a hereditary disease caused by autosomal dominant mutations involving chromosome 19. it is characterized by the presence of intestinal polyps, consistently in the jejunum, and mucocutaneous pigmentation with melanin spots of the lips, buccal mucosa, and digits.Proteus Syndrome
a very rare congenital disorder characterized by the development of multiple cutaneous and subcutaneous lesions including lipomas, nevi, and vascular malformations, associated with partial gigantism or digital overgrowth.Congenital Hamartoma
a hamartomatous lesion which is present at birth.
Patient EducationClinical
Genetic Disorders
Genetic disorders are health conditions caused by changes (also called mutations or variants) in your genes. Genes are parts of DNA found in your cells that carry instructions for how your body grows, develops, and functions. Many genes tell your body how to make proteins, which are needed for your body to work properly.
The full article covers:
- What are genetic disorders?
- What causes genetic disorders?
- What are the types of genetic disorders?
- What are the different ways a genetic disorder can be inherited?
- How are genetic disorders diagnosed?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Q85.9 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Q85.9Overview
Is Q85.9 (Phakomatoses, not elsewhere classified) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report phakomatosis, unspecified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does Q85.9 group to?
When phakomatosis, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 826, 827, 828, 829, 830, 843, 844, 845, with relative weights from 0.8516 to 4.6778 depending on complications. Higher weights mean higher Medicare reimbursement.
Is Q85.9 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for phakomatosis, unspecified on inpatient claims.
What is the ICD-9 equivalent of Q85.9?
Under the General Equivalence Mappings, phakomatosis, unspecified converts to ICD-9-CM 759.6 (hamartoses NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
